Journal Scans
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
ASCO Guidelines on Adjuvant Endocrine Therapy for Breast Cancer
HJ Burstein, AA Prestrud, J Seidenfeld, H Anderson, TA Buchholz, NE Davidson, KE Gelmon, SH Giordano, CA Hudis, J Malin, EP Mamounas, D Rowden, AJ Solky, MR Sowers, V Stearns, EP Winer, MR Somerfield, JJ Griggs
20100612
2010 Jul 12
J Clin Oncol
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
J Clin Oncol. 2010 Jul 12;[Epub Ahead of Print], HJ Burstein, AA Prestrud, J Seidenfeld, H Anderson, TA Buchholz, NE Davidson, KE Gelmon, SH Giordano, CA Hudis, J Malin, EP Mamounas, D Rowden, AJ Solky, MR Sowers, V Stearns, EP Winer, MR Somerfield, JJ Griggs
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
Recent publication of 12 landmark trials of endocrine therapy for women with hormone receptor–positive breast cancer spurred the American Society of Clinical Oncology (ASCO) to update its clinical practice guideline on this treatment. The Update Committee focused on the optimal adjuvant endocrine therapy strategy, using either tamoxifen or an aromatase inhibitor (AI), or both in sequence, that would lower the risk of recurrence. The committee also attempted to answer other clinical questions about...
